Position in PFE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,614,250
-$268,148 QoQ
Shares Held
67,037
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,055
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Capital Management, Inc. holds $39,718,306 across 10 Drug Manufacturers - General names. PFE ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
74,849 | $11,730,335 | |
| 2 | JNJ |
Johnson & Johnson
|
42,818 | $10,874,487 | |
| 3 | LLY |
ELI LILLY & Co
|
8,143 | $9,766,959 | |
| 4 | ABBV |
AbbVie Inc.
|
10,042 | $2,526,968 | |
| 5 | PFE |
Pfizer Inc
This page
|
67,037 | $1,614,250 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
14,350 | $826,847 | |
| 7 | AMGN |
Amgen Inc
|
2,224 | $805,354 | |
| 8 | MRK |
Merck & Co., Inc.
|
5,967 | $766,759 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,614,250 | 67,037 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,882,398 | 67,037 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,669,221 | 67,037 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,708,102 | 67,037 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,624,976 | 67,037 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,698,717 | 67,037 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,778,465 | 67,036 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,940,021 | 67,036 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,875,667 | 67,036 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,859,832 | 67,021 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,929,534 | 67,021 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,223,086 | 67,021 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,458,330 | 67,021 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,734,456 | 67,021 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,434,156 | 67,021 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,932,838 | 67,021 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,513,911 | 67,021 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,469,677 | 67,021 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,957,590 | 67,021 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,882,573 | 67,021 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,624,542 | 67,021 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,428,170 | 67,021 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,467,043 | 67,021 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,550,867 | 69,506 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,272,848 | 69,506 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,268,672 | 69,506 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||